Effects of antiarrhythmic drugs on QT interval dispersion - Relationship to antiarrhythmic action and proarrhythmia

Progress in Cardiovascular Diseases

Volumn 42, Issue 5, 2000, Pages 385-396

  Gillis, Anne M ^a,b  

^a UNIVERSITY OF CALGARY   (Canada)

^b 3330 Hospital Dr NW   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; AMIODARONE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOFETILIDE; ISOPRENALINE; MAGNESIUM; MEXILETINE; NICORANDIL; POTASSIUM; POTASSIUM CHANNEL STIMULATING AGENT; PROPAFENONE; QUINIDINE; SEMATILIDE; SOTALOL; VERAPAMIL;

ANTIARRHYTHMIC ACTIVITY; ARRHYTHMOGENESIS; CORONARY ARTERY DISEASE; DRUG CLASSIFICATION; DRUG EFFECT; DRUG EFFICACY; ELECTROCARDIOGRAPHY; HEART ELECTROPHYSIOLOGY; HEART INFARCTION; HEART REPOLARIZATION; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; NONHUMAN; QT INTERVAL; REVIEW; TORSADE DES POINTES;

EID: 0034029666     PISSN: 00330620     EISSN: None     Source Type: Journal    
DOI: 10.1053/pcad.2000.0420385     Document Type: Article

References (74)

1. Singh BN. Current antiarrhythmic drugs: An overview of mechanisms of action and potential clinical utility. J Cardiovasc Electrophysiol. 10:1999;283-301
2. Task Force of the Working Group on Arrhythmias of the European Society of Cardiology: The Sicilian Gambit. Circulation. 84:1991;1831-1851. A new approach to the classification of antiarrhythmic drugs based on their actions on arrhythmogenic mechanisms
3. Kuo CS, Atarashi H, Reddy CP, et al. Dispersion of ventricular repolarization and arrhythmia: Study of two consecutive ventricular premature complexes. Circulation. 72:1985;370-376
4. Surawicz B. Electrophysiologic substrate of torsade de pointes: Dispersion of repolarization or early afterdepolarizations? J Am Coll Cardiol. 14:1989;172-184
5. Antzelevitch C, Shimizu W, Yan GX, et al. Cellular basis for QT dispersion. J Electrocardiol. 30:1998;168-175
6. Day CP, McComb JM, Campbell RWF. QT dispersion: An indication of arrhythmia risk in patients with long QT intervals. Br Heart J. 63:1990;342-344
7. Buja G, Miorelli M, Turrini P, et al. Comparison of QT dispersion in hypertrophic cardiomyopathy between patients with and without ventricular arrhythmias and sudden death. Am J Cardiol. 72:1993;973-976
8. Yunus A, Gillis A, Duff H, et al. Increased precordial QTc dispersion predicts ventricular fibrillation during acute myocardial infarction. Am J Cardiol. 78:1996;706-708
9. Bogun F, Chan K, Harvey M, et al. QT dispersion in nonsustained ventricular tachycardia and coronary artery disease. Am J Cardiol. 77:1996;256-259
10. Barr CS, Naas A, Freeman M, et al. QT dispersion and sudden unexpected death in chronic heart failure. Lancet. 343:1994;327-329
11. Hii JTY, Wyse DG, Gillis AM, et al. Precordial QT interval dispersion as a marker of torsade de pointes: Disparate effects of class Ia antiarrhythmic drugs and amiodarone. Circulation. 86:1992;1376-1382
12. Priori SG, Napolitano C, Diehl L, et al. Dispersion of the QT interval. A marker of therapeutic efficacy in the idiopathic long QT syndrome. Circulation. 89:1994;1681-1689
13. Gillis AM, Traboulsi M, Hii JTY, et al. Antiarrhythmic drug effects on QT dispersion in patients undergoing electropharmacologic testing for ventricular tachycardia and fibrillation. Am J Cardiol. 81:1998;588-593
14. Dambrink JH, Sippens Groenewegen A, van Gilst WH, et al. Association of left ventricular remodeling and nonuniform electrical recovery expressed by nondipolar QRST integral map patterns in survivors of a first anterior myocardial infarction. Captopril and Thrombolysis Study Investigation. Circulation. 92:1995;300-312
15. Spargias KS, Lindsay SJ, Hall AS, et al. Ramipril reduces QT dispersion in patients with acute myocardial infarction and heart failure. Am J Cardiol. 83:1999;969-971
16. Statters DJ, Malik M, Ward DE, et al. QT dispersion: Problems of methodology and clinical significance. J Cardiovasc Electrophysiol. 5:1994;672-685
17. Kautzner J, Malik M. QT interval dispersion and its clinical utility. Pacing Clin Electrophysiol. 20:1997;2625-2640
18. Zabel M. Is dispersion of ventricular repolarization rate dependent? Pacing Clin Electrophysiol. 20:1997;2405-2411
19. Day CP, McComb JM, Matthews J, et al. Reduction in QT dispersion by sotalol following myocardial infarction. Eur Heart J. 12:1991;423-427
20. de Bruyne MC, Hoes AW, Kors JA, et al. QTc dispersion predicts cardiac mortality in the elderly. The Rotterdam Study. Circulation. 97:1998;467-472
21. Coumel P, Maison-Blanche P, Badilini F. Dispersion of ventricular repolarization: Reality? illusion? significance? Circulation. 97:1998;2491-2493
22. Lux RL, Fuller MS, Macleod RS, et al. QT dispersion: Dispersion of ventricular repolarization or dispersion of the QT interval? J Electrocardiol. 30:1997;176-180. (suppl)
23. Stramba-Badiale M, Goulene K, Schwartz PJ. Effects of β-adrenergic blockade on dispersion of ventricular repolarization in newborn infants with prolonged QT interval. Am Heart J. 134:1997;406-410
24. Sun Z-H, Swan H, Viitasalo M, et al. Effects of epinephrine and phenylephrine on QT interval dispersion in congenital long QT syndrome. J Am Coll Cardiol. 31:1998;1400-1405
25. Shimizu W, Ohe T, Kurita T, et al. Effects of verapamil and propranolol on early afterdepolarizations and ventricular arrhythmias induced by epinephrine in congenital long QT syndrome. J Am Coll Cardiol. 26:1995;1299-1309
26. Shimizu W, Kamakura S, Kurita T, et al. Influence of epinephrine, propranolol and atrial pacing on spatial distribution of recovery time measured by body surface mapping in congenital long QT syndrome. J Cardiovasc Electrophysiol. 8:1997;1102-1114
27. Shimizu W, Antzelevitch C. Cellular basis for the ECG features of the LQT1 form of the long-QT syndrome. Effects of β-adrenergic agonists and antagonists and sodium channel blockers on transmural dispersion of repolarization and torsade de pointes. Circulation. 98:1998;2314-2322
28. ks contributes to the longer action potential of the M cell. Circ Res. 76:1995;351-365
29. + channel blockade and to increases in heart rate: Implications for gene-specific therapy. Circulation. 92:1995;3381-3386
30. + channel blockade, β-adrenergic stimulation, and rapid pacing in a cellular model mimicking the SCN5A and HERG defects present in the long QT syndrome. Circ Res. 78:1996;1009-1015
31. Shimizu W, Antzelevitch C. Sodium channel block with mexilitine is effective in reducing dispersion of repolarization and preventing torsade de pointes in LQT2 and LQT3 models of the long-QT syndrome. Circulation. 96:1997;2038-2047
32. + channel opener in LQT1 form of congenital long QT syndrome. Circulation. 97:1998;1581-1588
33. Liu DW, Gintant GA, Antzelevitch C. Ionic bases for electrophysiological distinctions among epicardial, mid-myocardial, and endocardial myocytes from the free wall of the canine left ventricle. Circ Res. 72:1993;671-687
34. Gillis AM, Geonzon RA, Mathison HJ, et al. The effects of barium, dofetilide and 4-aminopyridine (4-AP) on ventricular repolarization in normal and hypertrophied rabbit heart. J Pharmacol Exp Ther. 289:1998;262-270
35. + currents from patients with terminal heart failure. Circ Res. 73:1993;379-385
36. Boyden PA, Jeck CD. Ion channel function in disease. Cardiovasc Res. 29:1995;312-318
37. Mitchell LB, Hubley-Kozey CL, Smith ER, et al. Electrocardiographic body surface potential mapping in patients with ventricular tachycardia. Assessment of utility in the identification of effective pharmacologic therapy. Circulation. 86:1992;383-393
38. Cui G, Sen L, Sager P, et al. Effect of amiodarone, sematilide and sotalol on QT dispersion. Am J Cardiol. 74:1994;896-900
39. Grimm W, Steder U, Menz V, et al. Effect of amiodarone on QT dispersion in the 12-lead standard electrocardiogram and its significance for subsequent arrhythmic events. Clin Cardiol. 20:1997;107-110
40. Meierhenrich R, Helquera ME, Kidwell GA, et al. Influence of amiodarone on QT dispersion in patients with life-threatening ventricular arrhythmias and clinical outcome. Int J Cardiol. 60:1997;289-294
41. Yi G, Elliott P, McKenna WJ, et al. QT dispersion and risk factors for sudden cardiac death in patients with hypertrophic cardiomyopathy. Am J Cardiol. 82:1998;1514-1519
42. Dritsas A, Gilligan D, Nihoyannopoulos P, et al. Amiodarone reduces QT dispersion in patients with hypertrophic cardiomyopathy. Int J Cardiol. 36:1992;345-349
43. Miorelli M, Buja G, Melacini P, et al. QT-interval variability in hypertrophic cardiomyopathy patients with cardiac arrest. Int J Cardiol. 45:1994;121-127
44. Mayet J, Shahi M, McGrath K, et al. Left ventricular hypertrophy and QT dispersion in hypertension. Hypertension. 28:1996;791-796
45. Mirvis DM. Spatial variation of QT intervals in normal persons and patients with acute myocardial infarction. J Am Coll Cardiol. 5:1985;625-631
46. Ichkhan K, Molnar J, Somberg J. Relation of left ventricular mass and QT dispersion in patients with systemic hypertension. Am J Cardiol. 79:1997;508-511
47. Gillis AM, Mathison HJ, Kulisz E, et al. Quinapril reduces dispersion of ventricular repolarization in a rabbit model of volume overload heart failure. Can J Cardiol. 14:1998;81F. (abstr)
48. González-Juanatey JR, García-Acuña JM, Pose A, et al. Reduction of QT and QTc dispersion during long-term treatment of systemic hypertension with analapril. Am J Cardiol. 81:1998;170-174
49. Barr CS, Naas AA, Fenwick M, et al. Enalapril reduces QTc dispersion in mild congestive heart failure secondary to coronary artery disease. Am J Cardiol. 79:1997;328-333
50. Domanski MJ, Exner DV, Borkowf CB, et al. Effect of angiotensin converting enzyme inhibition on sudden cardiac death in patients following acute myocardial infarction. A meta-analysis of randomized clinical trials. J Am Coll Cardiol. 33:1999;598-604
51. Hohnloser SH, Klingenheben T, Singh BN. Amiodarone-associated proarrhythmic effects. A review with special reference to torsade de pointes tachycardia. Ann Intern Med. 121:1994;529-535
52. Lehmann MH, Hardy S, Archibald D, et al. Sex difference in risk of torsade de pointes with d,1-sotalol. Circulation. 94:1996;2535-2541
53. Hohnloser SH, Singh BW. Proarrhythmia with Class III antiarrhythmic drugs: Definition, electrophysiologic mechanisms, incidence, predisposing factors, and clinical implications. J Cardiovasc Electrophysiol. 6:1995;920-936
54. Drouin E, Charpentier F, Gauthier C, et al. Electrophysiological characteristics of cells spanning the left ventricular wall of human heat: Evidence for the presence of M cells. J Am Coll Cardiol. 26:1995;185-192
55. Zabel M, Hohnloser SH, Behrens S, et al. Differential effects of d-sotalol, quinidine, and amiodarone on dispersion of ventricular repolarization in the isolated rabbit heart. J Cardiovasc Electrophysiol. 8:1997;1239-1245
56. Sicouri S, Moro S, Litovsky S, et al. Chronic amiodarone reduces transmural dispersion of repolarization in the canine heart. J Cardiovasc Electrophysiol. 8:1997;1269-1279
57. Tran HT, Chow MSS, Kluger J. Amiodarone induced torsade de pointes with excessive QT dispersion following quinidine induced polymorphic ventricular tachycardia. Pacing Clin Electrophysiol. 20:1997;2275-2278
58. Dancey D, Wulffhart Z, McEwan P. Sotalol-induced torsade de pointes in patients with renal failure. Can J Cardiol. 13:1997;55-58
59. Houltz B, Darpo B, Edvardsson W, et al. Electrocardiographic and clinical predictors of torsade de pointes induced by almokalant infusion in patients with chronic atrial fibrillation or flutter: A prospective study. Pacing Clin Electrophysiol. 21:1998;1044-1057
60. Hohnloser SH, van de Loo A, Baedeker F. Efficacy and proarrhythmic hazards of pharmacologic cardioversion of atrial fibrillation: Prospective comparison of sotalol versus quinidine. J Am Coll Cardiol. 26:1995;852-858
61. Sarubbi B, Ducceshi V, Briglia N, et al. Compared effects of sotalol, flecainide and propafenone on ventricular repolarization in patients free of underlying structural heart disease. Int J Cardiol. 66:1998;157-164
62. Demolis J-L, Funck-Brentano C, Ropers J, et al. Influence of dofetilide on the QT-interval duration and dispersion at various heart rates during exercise in humans. Circulation. 94:1996;1592-1599
63. Waldo AL, Camm AJ, de Ruyter H, et al. Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. The SWORD Investigators. Survival With Oral d-Sotalol. Lancet. 348:1996;7-12
64. Moller M. DIAMOND antiarrhythmic trials. Danish Investigations of Arrhythmia and Mortality on Dofetilide. Lancet. 348:1996;1597-1598
65. Faber TS, Zehender M, Krahnefeld O, et al. Propafenone during acute myocardial ischemia in patients: A double-blind randomized, placebo-controlled study. J Am Coll Cardiol. 29:1997;561-567
66. Puljevic D, Smalcelj A, Darakovic Z, et al. The influence of atenolol and propafenone on QT interval dispersion in patients 3 months after myocardial infarction. Int J Clin Pharmacol Ther. 35:1997;381-384
67. Kennedy JL. Beta-blocker prevention of proarrhythmia and proischemia: Clues from CAST, CAMIAT and EMIAT. Am J Cardiol. 80:1997;1208-1211
68. Verduyn SC, Vos MA, Van de Zande J, et al. Further observations to elucidate the role of interventricular dispersion of repolarization and early afterdepolarizations in the genesis of acquired torsade de pointes arrhythmias. A comparison between almokalant and d-sotalol using the dog as its own control. J Am Coll Cardiol. 30:1997;1575-1584
69. Volders PGA, Sipido KR, Vos MA, et al. Cellular basis of biventricular hypertrophy and arrhythmogenesis in dogs with chronic complete atrioventricular block and acquired torsade de pointes. Circulation. 98:1998;1136-1147
70. Gillis AM, Mathison HJ, Kulisz G, et al. Influence of ventricular dilation and potassium channel blockers on dispersion of ventricular repolarizations in hypertrophied rabbit hearts. Can J Cardiol. 13:1997;78C. (abstr)
71. Geonzon RA, Gunka V, Gillis AM, et al. Enhanced dofetilide-induced prolongation of cardiac action potential in pressure overload cardiac hypertrophy. Can J Cardiol. 13:1997;101C. (abstr)
72. Verduyn SC, Vos MA, Van der Zande J, et al. Role of interventricular dispersion of repolarization in acquired torsade de pointes arrhythmias: Reversal by magnesium. Cardiovasc Res. 34:1997;453-463
73. Parikka H, Toivonen L, Naukkarinen V, et al. Decreases by magnesium of QT dispersion and ventricular arrhythmias inpatients with acute myocardial infarction. Eur Heart J. 20:1999;111-120
74. Kr:subplications for torsade de pointes and reverse use-dependence. Circulation. 93:1996;407-411